Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
68 TWD | -0,58% | -4,36% | -22,73% |
Attività
Vendite per attività
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
New Drug Development
100,0
%
| 0 | nan % | 315 | 100,0 % | - |
Vendite per regione
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| - | - | 315 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Pei Kan
CEO | Chief Executive Officer | - | 01/04/18 |
Shu Ping Yang
DFI | Director of Finance/CFO | - | 01/06/15 |
Ko Chieh Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hui An Pao
COO | Chief Operating Officer | - | 19/09/16 |
Ju Yi Lin
ADM | Chief Administrative Officer | 58 | 01/06/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Li Jen Wu
BRD | Director/Board Member | - | 10/01/22 |
Ko Jui Shih
BRD | Director/Board Member | - | 25/10/21 |
Wen Chang Chang
BRD | Director/Board Member | - | 10/01/22 |
Chien Chih Wang
CHM | Chairman | - | 21/06/16 |
Yan Ling Fang
BRD | Director/Board Member | 66 | 10/01/22 |
Pei Kan
CEO | Chief Executive Officer | - | 01/04/18 |
Wen Hsu Yan
BRD | Director/Board Member | - | - |
Chi Heng Chien
BRD | Director/Board Member | - | - |
Te Chun Kung
BRD | Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 129 018 004 | 79 397 004 ( 61,54 %) | 0 | 61,54 % |
Coordinate società
Pharmosa Biopharm, Inc.
3/F-3, 66 Sanchong Road Nangang District
115602, Taipei
+
http://www.pharmosa.com.twSettore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
-22,73% | 270 Mln | |
+18,97% | 45,34 Mrd | |
+41,98% | 40,42 Mrd | |
-10,06% | 37,92 Mrd | |
+31,15% | 31,75 Mrd | |
-7,79% | 27,71 Mrd | |
+13,32% | 26,52 Mrd | |
+43,05% | 13,96 Mrd | |
+31,28% | 12,44 Mrd | |
-7,41% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione 6875
- Società Pharmosa Biopharm Inc.